Keyword: Bristol-Myers Squibb (BMS)
News
11.08.2021
-
WuXi STA, CDMO subsidiary of WuXi AppTec, has completed the acquisition of a drug product manufacturing facility in Couvet, Switzerland, from US pharma Bristol Myers...
News
02.06.2021
-
US drugmaker Bristol Myers Squibb has signed an exclusive license agreement for Agenus’ proprietary bispecific antibody program AGEN1777, that blocks TIGIT and a second...
News
29.04.2021
-
US drugmaker Bristol Myers Squibb has chosen Leiden in the Netherlands for a new cell therapy manufacturing site in Europe as it continues to expand and develop...
News
11.02.2021
-
China contract development and manufacturing organization (CDMO) WuXi STA has agreed to buy Bristol Myers Squibb’s manufacturing facility in Couvet, Switzerland, for an...
News
08.10.2020
-
Bristol Myers Squibb is buying cardiovascular specialist MyoKardia for $13.1 billion, gaining rights to mavacamten, an experimental heart disease treatment that could...
Plant Construction & Process Technology
14.04.2020
- Established in 2004 by the International Society for Pharmaceutical Engineering (ISPE), the Facility of the Year Awards (FOYA) recognize innovation and creativity in manufacturing...
News
20.11.2019
- The US Federal Trade Commission has approved Bristol-Myers Squibb’s $74 billion takeover of biotech Celgene by a vote of 3 to 2. The biggest merger in the history of the global...
Markets & Companies
13.09.2019
- Abbvie takes over Allergan, Pfizer merges its generics business with Mylan, Takeda integrates Shire — the pharmaceutical industry is making a name for itself in 2019 with several...
